4.6 Article

Clinical and Genetic Features of Chinese Patients With NIPA1-Related Hereditary Spastic Paraplegia Type 6

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Genotype-phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patients

Maryam Erfanian Omidvar et al.

Summary: This study conducted a systematic meta-analysis of genotype-phenotype associations in HSP patients, revealing specific mutated genes are associated with age of disease onset and specific sub-phenotypes. The findings could be beneficial for diagnosis and differentiation of the specific mutated genes phenotype among different forms of HSP.

JOURNAL OF NEUROLOGY (2021)

Article Biotechnology & Applied Microbiology

The emerging genetic diversity of hereditary spastic paraplegia in Korean patients

Jin Ok Yang et al.

Summary: This study identified 88 genetic variants in 54 genes from whole-exome data of 82 clinically well-defined Korean HSP families, expanding the genetic spectrum for HSP and potentially contributing to more accurate diagnosis and treatment for rare HSP. The inheritance modes varied, with 39 de novo, 33 autosomal dominant, and 10 autosomal recessive cases. Furthermore, the study revealed differences in the genetic spectrum and variation of known HSP genes across ethnic groups.

GENOMICS (2021)

Review Clinical Neurology

SPG6 (NIPA1 variant): A report of a case with early-onset complex hereditary spastic paraplegia and brief literature review

Carlotta Spagnoli et al.

Summary: SPG6 is considered a pure autosomal dominant hereditary spastic paraplegia (AD-HSP), but complex cases have also been reported with comorbidities such as epilepsy. A common pathogenic variant in SPG6 is found to be associated with drug-resistant eyelid myoclonia with absences, suggesting a diverse clinical spectrum. Seizures in SPG6 may not always respond to medication, contrary to previous descriptions.

JOURNAL OF CLINICAL NEUROSCIENCE (2021)

Article Genetics & Heredity

A novel de novo NIPA1 missense mutation associated to hereditary spastic paraplegia

Dora Fabbro et al.

Summary: This study presents a case of SPG6 patient with the NIPA1 p.Asn83Lys mutation, leading to clinical symptoms. Molecular modeling suggests a significant impact of this mutation on the protein structure.

JOURNAL OF HUMAN GENETICS (2021)

Article Geriatrics & Gerontology

Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort

Gij S. H. P. Tazelaar et al.

NEUROBIOLOGY OF AGING (2019)

Article Genetics & Heredity

Genetic and Clinical Profile of Chinese Patients with Autosomal Dominant Spastic Paraplegia

Miao Zhao et al.

MOLECULAR DIAGNOSIS & THERAPY (2019)

Article Genetics & Heredity

Targeted next-generation sequencing improves diagnosis of hereditary spastic paraplegia in Chinese patients

Cong Lu et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2018)

Article Neurosciences

Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China

En-Lin Dong et al.

MOLECULAR NEURODEGENERATION (2018)

Article Clinical Neurology

Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study

Angelica D'Amore et al.

FRONTIERS IN NEUROLOGY (2018)

Article Clinical Neurology

Genetic background of the hereditary spastic paraplegia phenotypes in Hungary - An analysis of 58 probands

Peter Balicza et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)

Letter Clinical Neurology

Pure hereditary spastic paraplegia due to a de novo mutation in the NIPA1 gene

D. Arkadir et al.

EUROPEAN JOURNAL OF NEUROLOGY (2014)

Article Clinical Neurology

Recurrent de novo c.316G>A mutation in NIPA1 hotspot

Peter Hedera

JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)

Article Clinical Neurology

TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation

Maria Martinez-Lage et al.

ACTA NEUROPATHOLOGICA (2012)

Article Clinical Neurology

Expansion of the phenotypic spectrum of SPG6 caused by mutation in NIPA1

Juan Du et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2011)

Article Clinical Neurology

NIPA1 mutation in complex hereditary spastic paraplegia with epilepsy

K. Svenstrup et al.

EUROPEAN JOURNAL OF NEUROLOGY (2011)

Article Clinical Neurology

Clinical and genetic study of SPG6 mutation in a Chinese family with hereditary spastic paraplegia

Shi Guo Liu et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)

Article Clinical Neurology

Screening of hereditary spastic paraplegia patients for alterations at NIPA1 mutational hotspots

Christian Beetz et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)

Article Biochemistry & Molecular Biology

NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter

Angela Goytain et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Clinical Neurology

Childhood-onset spastic paraplegia with NIPA1 gene mutation

Ricardo Bien-Willner et al.

JOURNAL OF CHILD NEUROLOGY (2006)

Article Clinical Neurology

Clinical and genetic study of a Brazilian family with spastic paraplegia (SPG6 locus)

RP Munhoz et al.

MOVEMENT DISORDERS (2006)

Article Genetics & Heredity

NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6)

S Rainier et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2003)